Aug 30, 2011
Charles R. Cantor, Chief Scientific Officer at Sequenom and Member of the US National Academy of Sciences, to give a plenary keynote presentation at the 7th Modern Drug Discovery and Development Summit (Oct 19-21, 2011 in San Diego, CA)
Aug 30, 2011
William R. Strohl, Vice President of Biologics Research at Johnson & Johnson, to give a plenary keynote presentation at the 7th Modern Drug Discovery and Development Summit (Oct 19-21, 2011 in San Diego, CA)
Aug 25, 2011
Biosimilars and FDA talk at 4th Protein Therapeutics Conference Oct 19-21
Aug 16, 2011
Yibing Shan, Senior Scientist of Chemistry and Biology at D. E. Shaw Research, to give a presentation at 5th Drug Design and Medicinal Chemistry Conference (Oct 19-21, 2011 in San Diego, CA)
Aug 16, 2011
Juswinder Singh, Co-Founder and Chief Scientific Officer at Avila Therapeutics, to give a presentation at 5th Drug Design and Medicinal Chemistry Conference (Oct 19-21, 2011 in San Diego, CA)
Aug 16, 2011
Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for BioMedical Research, to speak at 5th Drug Design and Medicinal Chemistry Conference (Oct 19-21, 2011 in San Diego, CA)
Aug 16, 2011
Suvit Thaisrivongs, Head of Medicinal Chemistry, Immunology and Autoimmunity Research at Pfizer, to give a featured presentation at 5th Drug Design and Medicinal Chemistry Conference (Oct 19-21, 2011 in San Diego, CA)
Aug 15, 2011
Dr. Jon Heinrichs, Director, Microbial Vaccines, Merck Research Laboratories, to deliver featured presentation at “9th Annual Vaccines Discovery and Development: All Things Considered” conference, to be held on Nov. 7-8, 2011 in Boston by GTC.
Aug 15, 2011
Dr. Joseph Joyce, Director, Vaccine Research, Merck Research Laboratories, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA).
Aug 11, 2011
Susan Siegel Ph.D. and William Noonan M.D. of Klarquist Sparkman to give a featured presentation entitled “Patenting Protein Therapeutics: In the Shadow of Uncertainty” at GTC’s 4th Protein Discovery & Therapeutics Conference on Oct 19-21, 2011